-
公开(公告)号:US20200222294A1
公开(公告)日:2020-07-16
申请号:US16827033
申请日:2020-03-23
Applicant: Shiseido Company, Ltd.
Inventor: Mio Nakamura , Kentaro KAJIYA , Shinichiro HAZE
IPC: A61K8/49 , A61K36/61 , A61K8/37 , A61Q19/08 , A61K31/22 , A61K31/351 , A61K8/92 , A61K36/738 , A61Q19/06
Abstract: The purpose of this invention is to find a novel fragrance component effective for prevention or control of swelling, lymphedema, skin aging or obesity from the viewpoint of activation of lymph vessel function by promotion of the expression of VEGFC. This invention provides a swelling improving agent, lymph vessel activator and VEGFC production promoter characterized by containing one or a plurality of components selected from the group consisting of rose oxide, citronellyl acetate and niaouli oil.
-
公开(公告)号:US20150328137A1
公开(公告)日:2015-11-19
申请号:US14431837
申请日:2013-09-27
Applicant: Shiseido Company Ltd.
Inventor: Mio NAKAMURA , Kentaro KAJIYA , Shinichiro HAZE
CPC classification number: A61K8/498 , A61K8/37 , A61K8/922 , A61K31/22 , A61K31/351 , A61K36/61 , A61K36/738 , A61Q19/007 , A61Q19/06 , A61Q19/08 , A61Q19/10 , A61K2300/00
Abstract: The purpose of this invention is to find a novel fragrance component effective for prevention or control of swelling, lymphedema, skin aging or obesity from the viewpoint of activation of lymph vessel function by promotion of the expression of VEGFC. This invention provides a swelling improving agent, lymph vessel activator and VEGFC production promoter characterized by containing one or a plurality of components selected from the group consisting of rose oxide, citronellyl acetate and niaouli oil.
Abstract translation: 本发明的目的是通过促进VEGFC的表达,从激活淋巴管功能的角度,找到有效预防或控制肿胀,淋巴水肿,皮肤老化或肥胖的新颖香味成分。 本发明提供一种溶胀改善剂,淋巴管活化剂和VEGFC生产促进剂,其特征在于含有一种或多种选自玫瑰氧化物,香茅醇乙酸酯和粘液油的成分。
-
公开(公告)号:US20230172837A1
公开(公告)日:2023-06-08
申请号:US17919954
申请日:2021-04-19
Applicant: SHISEIDO COMPANY, LTD.
Inventor: Satoshi HORIBA , Junichi HOSOI , Daigo INOUE , Kentaro KAJIYA , Masaya TAKAGI , Yuko MATSUURA , Masato IINO
IPC: A61K8/9761 , A61Q19/02 , A61Q19/08 , A45D44/22
CPC classification number: A61K8/9761 , A61Q19/02 , A61Q19/08 , A45D44/22
Abstract: The present invention provides an agent for preventing and/or improving photoaging and/or dermal pigmentation comprising Thujae Semen extract as an active ingredient. The present invention also provides a cosmetic method which includes a step for applying the agent for preventing and/or improving photoaging and/or dermal pigmentation to skin to be treated, and a cosmetic device to be applied in said method.
-
公开(公告)号:US20210077556A1
公开(公告)日:2021-03-18
申请号:US16764573
申请日:2018-11-15
Applicant: Shiseido Company, Ltd.
Inventor: Kentaro KAJIYA , Yuuko MATSUMOTO
IPC: A61K36/06 , A61K36/254 , A61K36/28 , A61K36/64
Abstract: The purpose of the present invention is to provide a substance related to the stabilization of capillary blood vessels. This invention is based on the discovery that an extract from a plant selected from the group consisting of Calendula officinalis, Siberian ginseng, and Cistanche salsa increases gene expression of VE-cadherin or integrin α5.
-
公开(公告)号:US20220128438A1
公开(公告)日:2022-04-28
申请号:US17572227
申请日:2022-01-10
Applicant: SHISEIDO COMPANY, LTD.
Inventor: Kentaro KAJIYA , Toyonobu YAMASHITA
Abstract: The present invention address the problem of providing a transparent skin sample by removing epidermis via enzymatic treatment.
-
公开(公告)号:US20170281500A1
公开(公告)日:2017-10-05
申请号:US15625080
申请日:2017-06-16
Applicant: Shiseido Company, Ltd.
Inventor: Mio Nakamura , Kentaro KAJIYA , Shinichiro HAZE
IPC: A61K8/49 , A61Q19/08 , A61K31/351 , A61K8/37 , A61K31/22
CPC classification number: A61K8/498 , A61K8/37 , A61K8/922 , A61K31/22 , A61K31/351 , A61K36/61 , A61K36/738 , A61Q19/007 , A61Q19/06 , A61Q19/08 , A61Q19/10 , A61K2300/00
Abstract: The purpose of this invention is to find a novel fragrance component effective for prevention or control of swelling, lymphedema, skin aging or obesity from the viewpoint of activation of lymph vessel function by promotion of the expression of VEGFC. This invention provides a swelling improving agent, lymph vessel activator and VEGFC production promoter characterized by containing one or a plurality of components selected from the group consisting of rose oxide, citronellyl acetate and niaouli oil.
-
-
-
-
-